Evercore Wealth Management, LLC Aveo Pharmaceuticals, Inc. Transaction History

Evercore Wealth Management, LLC

  • $6.66 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$5.12 - $6.89 $2,549 - $3,431
498 Added 1.2%
41,841 $259,000
Q2 2021

Aug 16, 2021
SELL
$6.21 - $7.45 $30,950 - $37,130
-4,984 Reduced 10.76%
41,343 $272,000
Q4 2020

Feb 16, 2021
BUY
$5.08 - $6.68 $25,318 - $33,293
4,984 Added 12.06%
46,327 $268,000
Q1 2020

May 14, 2020
BUY
$2.6 - $6.9 $107,491 - $285,266
41,343 New
41,343 $150,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Evercore Wealth Management, LLC Portfolio

Follow Evercore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email